Home / Inspections / 1121115

FDA Inspection 1121115 — LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC

LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC — FEI 3008307571

The FDA completed an inspection of LifeCell Corporation, A Wholly Owned Subsidiary of Allergan PLC on February 20, 2020 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Branchburg, NJ (United States)

Facility

Other inspections at this facility

  • 1027719 (NAI Wed Sep 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 979341 (NAI Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 929139 (NAI Thu May 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 848457 (NAI Mon Sep 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 742148 (NAI Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources